Cervical TCT with benign reactive cell changes suggesting inflammation means that the result of cervical cytology is an inflammatory lesion without much problem. Cervical TCT is a cytologic pathology test that is used for early screening of cervical cancer along with HPV testing. If the screening result is reactive cell changes suggesting inflammation, it means that the nature of the lesion in the cervical area is just simple cervicitis and there is no risk of precancerous lesions is a relatively good test result. If the patient is accompanied by obvious manifestations of inflammatory diseases such as abnormal leucorrhea, itching, odor, contact bleeding, or the report sheet suggests that trichomonas, mycobacteria, etc. are visible depending on the pathogens used, you can choose unused drugs for symptomatic treatment such as povidone-containing suppositories, metronidazole preparations, nifurtimox, shanking and other drugs.